lorazepam
UkraineDrugs containing this active substance
-
The drug is used to treat anxiety states, tension, and agitation. It is also prescribed for insomnia, as an adjunct therapy for depression and schizophrenia, and for sedation before medical interventions.
Form: tablets
Active substance Dosage lorazepam 1 mg ATC: N05BA06
Manufacturer: LLC "Kharkiv Pharmaceutical Enterprise "Zdorovya Narodu"
-
The drug is used to treat anxiety states, tension, and agitation. It is also used for insomnia, as an adjunctive therapy in depression and schizophrenia, and for sedation before medical procedures.
Form: tablets
Active substance Dosage lorazepam 2.5 mg ATC: N05BA06
Manufacturer: LLC "Kharkiv Pharmaceutical Enterprise "Zdorovya Narodu"
-
The drug is used for sedation before medical procedures to reduce fear and tension, as well as for the treatment of severe anxiety states, phobias, and status epilepticus.
Form: solution for injection
Active substance Dosage lorazepam 2 mg/ml ATC: N05BA06
Manufacturer: LLC "Kharkiv Pharmaceutical Enterprise "Zdorovya Narodu"
-
The drug is used for the short-term treatment of anxiety, states of tension, agitation, and sleep disorders caused by these conditions. It is also used as premedication before diagnostic procedures or surgeries.
Form: tablets
Active substance Dosage lorazepam 0.5 mg ATC: N05BA06
Manufacturer: Tarchomin Pharmaceutical Plant "Polfa" S.A.
-
The drug is used for the short-term treatment of anxiety, states of tension, agitation, and sleep disorders caused by these conditions. It is also used to prepare for diagnostic interventions or surgeries.
Form: tablets
Active substance Dosage lorazepam 1 mg ATC: N05BA06
Manufacturer: Tarchomin Pharmaceutical Plant "Polfa" S.A.
-
The drug is used for the short-term treatment of anxiety, states of tension, agitation, and sleep disorders caused by these conditions. It is also used as preparation before diagnostic interventions or before and after surgery.
Form: tablets
Active substance Dosage lorazepam 2.5 mg ATC: N05BA06
Manufacturer: Tarchomin Pharmaceutical Plant "Polfa" S.A.